Filing Details
- Accession Number:
- 0001104659-17-037045
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-01 20:49:21
- Reporting Period:
- 2017-05-30
- Filing Date:
- 2017-06-01
- Accepted Time:
- 2017-06-01 20:49:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1641640 | Nabriva Therapeutics Ag | NBRV | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1554194 | Harrison George Talbot | 1000 Continental Drive Suite 600 King Of Prussia PA 19406 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2017-05-30 | 110 | $101.50 | 3,449 | No | 4 | S | Direct | |
| Common Shares | Disposition | 2017-05-30 | 100 | $101.00 | 3,349 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The common shares whose sale is reported on this line are represented by American Depositary Shares ("ADSs"). Each ADS represents one tenth (1/10) of a common share of Nabriva Therapeutics AG. The reporting person may hold both common shares and ADSs representing common shares, and Column 5 reports such holdings on an aggregate basis in terms of the corresponding number of common shares.
- The price of $101.50 per common share was derived from the sale price on May 30, 2017, of $10.15 per ADS, multiplied by ten.
- The price of $101.00 per common share was derived from the sale price on May 30, 2017, of $10.10 per ADS, multiplied by ten.
Billionaire Hedge Funds
